13G Filing: Paulson & Co and Enzymotec Ltd (ENZY)

Published on September 12, 2017 at 3:03 pm by Insider Monkey Staff in Hedge Funds

Page 1 of 6

Enzymotec Ltd (NASDAQ:ENZY): John Paulson’s Paulson & Co filed an amended 13D.

You can check out Paulson & Co’s latest holdings and filings here.

Please follow Paulson & Co (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Paulson & Co or update its stock holdings.

John Paulson

Paulson & Co

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name	Sole Voting Power	Shared Voting Power	Sole Dispositive Power	Shared Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Paulson Co. Inc	2,102,990	0	2,102,990	0	2,102,990	9.17%

John Paulson

Paulson & Co

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 1 of 6 – SEC Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(RULE 13d – 102)

Under the Securities Exchange Act of 1934
(Amendment No. 4)*

Enzymotec Ltd.

(Name of Issuer)

Ordinary Shares, par value NIS$0.01 per share

(Title of Class of Securities)

M4059L101

(CUSIP Number)

August 23, 2017

(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[x] Rule 13d-1(b)

[ ] Rule 13d-1(c)

[ ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Enzymotec Ltd.Follow Enzymotec Ltd.

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 1 of 6

Next >>

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.

We may use your email to send marketing emails about our services. Click here to read our privacy policy.